GIP/GLP-1 RA Beneficial for Patients With Opioid, Alcohol Use Disorder

FRIDAY, Oct. 25, 2024-- For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RA) are associated with...